Acelyrin Operating Income

Acelyrin (SLRN) currently reports a operating income of $-290M as of March 2025. That compares with $-330M in the prior-year period — up 9.7% year over year. Use the charts on this page to explore Acelyrin's operating income history and peer comparisons.

Acelyrin's operating income increased from $-330M to $-290M — a 9.7% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelyrin reported $-290M in operating income as of March 2025. That compares with $-330M in the prior-year period — up 9.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-290M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.